Document is current
Any future updates will be listed below
-
Authors
Hong, Catherine
Epstein, Joel B.
Jensen, Siri Beier
Gueiros, Luiz Alcino
van Leeuwen, Stephanie J. M.
Kandwal, Abhishek
Vissink, Arjan
Elad, Sharon
- License Information
-
More Information
Article History
Received: 7 June 2024
Accepted: 24 June 2024
First Online: 25 July 2024
Declarations
:
: Not applicable.
: Not applicable.
: Not Applicable.
: C. Hong, S. Beier Jensen, A. Kandwal, S.J.M. van Leeuwen, A. Vissink, L.A. Gueiros, and S. Elad reported no relevant financial or non-financial interests to disclose. J.B. Epstein is a consultant for Galera Therapeutics, Janssen, Biopharmaceuticals, Nestle Healthcare, and Tosk Inc. J.B. Epstein is a consultant for and has funded research from SaNOtize Research and Development Corp<i>.</i> J.B. Epstein is Associate Editor-in-Chief for Supportive Care in Cancer.
: The MASCC/ISOO OCSG Statements have been developed to facilitate expert-opinion-based management of oral complications of cancer and cancer therapy, where high-quality evidence is lacking. Clinicians should use their judgment when making treatment decisions for individual patients. Statement authors and the MASCC/ISOO do not guarantee or take responsibility for the clinical outcomes in individual patients.
